No Data
zhejiang jianfeng group (600668.SH): Subsidiary passes pharmaceutical GMP compliance inspection.
On November 13, Gelonhui announced that its wholly-owned subsidiary, Zhejiang Jianfeng Pharmaceutical Co., Ltd., obtained the announcement of the results of pharmaceutical GMP compliance inspection from the Zhejiang Provincial Food and Drug Administration website. This pharmaceutical GMP compliance inspection result obtained by Jianfeng Pharmaceutical indicates that the production lines of the subsidiary comply with GMP requirements, which is beneficial to ensuring product quality and production capacity, establishing a stable production capacity, and further enriching the company's product line.
Zhejiang Jianfeng Group's (SHSE:600668) Anemic Earnings Might Be Worse Than You Think
zhejiang jianfeng group (600668.SH): The company does not produce vitamins.
Gelonghui November 5th, zhejiang jianfeng group (600668.SH) stated on the investor interaction platform that the company does not produce vitamins.
Jianfeng Group Third Quarter Report 2024
Announcement of Jianfeng Group on the company\'s main operating data for the third quarter of 2024
Zhejiang Jianfeng Group (600668.SH) released its net income for the first three quarters, which decreased by 45.06% year-on-year to 70.5623 million yuan.
zhejiang jianfeng group (600668.SH) released the report for the first three quarters of 2024, during the reporting period, the company achieved revenue...
There's No Escaping Zhejiang Jianfeng Group Co., Ltd.'s (SHSE:600668) Muted EarningsNo Data
No Data
